Exploration of efficacy and safety of participants exposed to Vortioxetine and Escitalopram for Major Depressive order patients.
Phase 4
Not yet recruiting
- Conditions
- Health Condition 1: F339- Major depressive disorder, recurrent, unspecified
- Registration Number
- CTRI/2024/04/066519
- Lead Sponsor
- nil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1)Adult Patients (18-65 years old) diagnosed with MDD based on DSM-5 criteria.
2) Patients Presenting to the tertiary Care Hospital outpatient Department with moderate to severe symptoms.
3) Willingness to Provide informed consent for participation in the study.
Exclusion Criteria
•Patients with a history of bipolar disorder, psychotic disorder, or substance abuse within the past six months.
•Concurrent use of other antidepressants or psychotropic medications.
•Patients with previous depression resistant to antidepressants and those who had taken treatment with ECT in previous 3 months or formal psychotherapy within 1 month.
•Pregnancy or lactation.
•Patients with drug intake for psychosis or anxiety.
•Any history of allergy to the drugs.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method